AI and Medical Big Data. Working Together.
Enterprise-class medical transaction clearinghouses curate databases comprising
the health histories of over 310 million U.S. citizens, including detailed lab
and diagnostic data (EMR/EHR data) for more than 80 million patients. As of
January 2023, new federal legislation (The Consolidated Appropriations Act of
2021) now requires all payers to disclose their negotiated rates and other
key data in the form of machine-readable files, revealing the details of
their negotiated rates across every health plan - down to the individual procedure
and medical provider level.
All of this data can be aggregated and cross-referenced to create the first comprehensive snapshot of the entire U.S. healthcare system.
Taken together, these aggregated data resources offer an unprecedented opportunity to integrate, analyze, and render new business intelligence that will enable the next generation of healthcare and legal services.
Hagimo Holdings, LLC is at the forefront of this revolution. Contact us to learn more.
All of this data can be aggregated and cross-referenced to create the first comprehensive snapshot of the entire U.S. healthcare system.
Taken together, these aggregated data resources offer an unprecedented opportunity to integrate, analyze, and render new business intelligence that will enable the next generation of healthcare and legal services.
Hagimo Holdings, LLC is at the forefront of this revolution. Contact us to learn more.
Today's landscape offers a wealth of medical data and AI-driven insights, more extensive than widely
recognized. This encompasses detailed medical claims, comprehensive provider information, extensive
facility data, and up-to-the-minute details on every payer and health plan, including exact negotiated
rates for each procedure by individual medical provider. Crucially, complete medical histories,
integrating both structured and unstructured data, are now swiftly accessible for individuals or
on behalf of clinical trial sponsors or legal entities.
These rich data resources can streamline human clinical drug trials and mass-tort / settlement actions, enabling more efficient and accurate participant selection and outcome tracking. In other industry verticals, they lay the groundwork for advanced AI and machine learning applications, facilitating cutting-edge approaches in GIS mapping, media market analytics, and longitudinal assessments of patient cohorts. These tools enhance the efficiency and effectiveness of clinical and legal processes, transforming how healthcare and legal industries operate.
All you have to do is choose the right partner to help you navigate through these new resources. Click here to learn more.
These rich data resources can streamline human clinical drug trials and mass-tort / settlement actions, enabling more efficient and accurate participant selection and outcome tracking. In other industry verticals, they lay the groundwork for advanced AI and machine learning applications, facilitating cutting-edge approaches in GIS mapping, media market analytics, and longitudinal assessments of patient cohorts. These tools enhance the efficiency and effectiveness of clinical and legal processes, transforming how healthcare and legal industries operate.
All you have to do is choose the right partner to help you navigate through these new resources. Click here to learn more.